Cotinga Pharmaceuticals Inc. (COTQF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2018 | 1.92 Million USD | -59.64% |
| 2017 | 4.75 Million USD | -4.78% |
| 2016 | 4.99 Million USD | 63.99% |
| 2015 | 3.04 Million USD | 45.46% |
| 2014 | 2.09 Million USD | 11.2% |
| 2013 | 1.88 Million USD | -5.09% |
| 2012 | 1.98 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2019 Q2 | 254.06 USD | 1.81% |
| 2019 Q3 | 261.17 USD | 2.8% |
| 2019 Q1 | 249.54 USD | -58.27% |
| 2018 Q4 | 597.94 USD | 276.19% |
| 2018 FY | 1.92 Million USD | -59.64% |
| 2018 Q1 | 457.26 USD | -44.63% |
| 2018 Q2 | 273.24 USD | -40.25% |
| 2018 Q3 | 158.95 USD | -41.83% |
| 2017 Q3 | 583.98 USD | -4.12% |
| 2017 Q2 | 609.04 USD | 87.04% |
| 2017 Q1 | 325.62 USD | -64.11% |
| 2017 FY | 4.75 Million USD | -4.78% |
| 2017 Q4 | 825.78 USD | 41.41% |
| 2016 Q4 | 907.30 USD | 96.25% |
| 2016 Q3 | 462.32 USD | 1002.66% |
| 2016 FY | 4.99 Million USD | 63.99% |
| 2016 Q2 | 41.93 USD | -96.88% |
| 2016 Q1 | 1345.54 USD | -14.13% |
| 2015 FY | 3.04 Million USD | 45.46% |
| 2015 Q4 | 1566.92 USD | 712.06% |
| 2015 Q3 | 192.96 USD | -58.9% |
| 2015 Q2 | 469.49 USD | -12.27% |
| 2015 Q1 | 535.18 USD | 18.31% |
| 2014 FY | 2.09 Million USD | 11.2% |
| 2014 Q3 | 484.02 USD | -10.77% |
| 2014 Q2 | 542.42 USD | -22.71% |
| 2014 Q1 | 701.77 USD | 12.19% |
| 2014 Q4 | 452.36 USD | -6.54% |
| 2013 Q4 | 625.53 USD | 34.64% |
| 2013 FY | 1.88 Million USD | -5.09% |
| 2013 Q2 | 469.21 USD | 29.23% |
| 2013 Q1 | 363.08 USD | -6.95% |
| 2013 Q3 | 464.58 USD | -0.99% |
| 2012 FY | 1.98 Million USD | 0.0% |
| 2012 Q4 | 390.20 USD | -27.59% |
| 2012 Q2 | 568.60 USD | 0.0% |
| 2012 Q3 | 538.89 USD | -5.23% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 29.55 Million USD | 93.5% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -393.089% |
| Nascent Biotech, Inc. | 2.22 Million USD | 13.856% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -362.335% |
| Qrons Inc. | 643.67 Thousand USD | -198.427% |
| Rebus Holdings, Inc. | 664 Thousand USD | -189.293% |
| Skye Bioscience, Inc. | 13.54 Million USD | 85.821% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | 94.844% |
| Adynxx, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | 96.656% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | 88.002% |
| Arch Therapeutics, Inc. | 5.04 Million USD | 61.902% |
| Burzynski Research Institute, Inc. | 1.33 Million USD | -43.842% |
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | 97.787% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 60.941% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -633.938% |
| SQZ Biotechnologies Company | 85.61 Million USD | 97.756% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | 34.131% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -27.898% |
| Mesoblast Limited | 5.9 Million USD | 67.453% |
| Marizyme, Inc. | 19.23 Million USD | 90.016% |
| Genus plc | 147.7 Million USD | 98.699% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | 78.12% |
| Pharming Group N.V. | 225.49 Million USD | 99.148% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | 6.238% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -43.186% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | 76.965% |
| ContraFect Corporation | 56.88 Million USD | 96.623% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | 56.429% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -29.9% |
| IMV Inc. | 37.7 Million USD | 94.906% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | 31.159% |
| MultiCell Technologies, Inc. | 567.42 USD | -338433.362% |
| ONE Bio Corp. | 6.44 Million USD | 70.19% |
| Accustem Sciences Inc. | 3.74 Million USD | 48.727% |
| RVL Pharmaceuticals plc | 85.94 Million USD | 97.765% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 531.96 Thousand USD | -261.098% |
| Q BioMed Inc. | 3.43 Million USD | 44.105% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | 92.228% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | 26.893% |
| Biomind Labs Inc. | 994.18 Thousand USD | -93.215% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | 98.066% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -9.162% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | 71.407% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -3.032% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 7783.624% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -4.676% |
| GB Sciences, Inc. | 1.42 Million USD | -35.227% |
| Alpha Cognition Inc. | 9.7 Million USD | 80.208% |
| HST Global, Inc. | 140.9 Thousand USD | -1263.244% |
| CSL Limited | 3.44 Billion USD | 99.944% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -70.761% |
| Halberd Corporation | 74.84 Thousand USD | -2466.615% |
| Enzolytics Inc. | 2.17 Million USD | 11.865% |
| Agentix Corp. | 1.37 Million USD | -40.033% |
| Resverlogix Corp. | 12.71 Million USD | 84.889% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | 47.383% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.53 Billion USD | 99.875% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -83.995% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | 20.126% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -21.626% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | 43.585% |
| AVAX Technologies, Inc. | 7.31 Million USD | 73.723% |
| Zenith Capital Corp. | 8.94 Million USD | 78.521% |
| Genscript Biotech Corporation | 825.34 Million USD | 99.767% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -10926.382% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | 21.765% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -1020.003% |
| Kadimastem Ltd | 2.41 Million USD | 20.298% |
| Helix BioMedix, Inc. | 1.97 Million USD | 2.593% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 10.86 Million USD | 82.323% |
| BioStem Technologies, Inc. | 22.97 Million USD | 91.639% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -958.438% |
| LadRx Corporation | 3.81 Million USD | 49.606% |
| Cell Source, Inc. | 4.32 Million USD | 55.59% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -108.001% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -108.001% |
| NovAccess Global Inc. | 2.46 Million USD | 22.128% |
| Affymax, Inc. | 39.38 Million USD | 95.123% |
| Itoco Inc. | 919.14 Thousand USD | -108.989% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | 54.679% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -71.663% |
| Mobile Lads Corp. | 554.54 Thousand USD | -246.393% |
| CytoDyn Inc. | 18.05 Million USD | 89.363% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -7532.031% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -772.83% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -35.295% |
| SYBLEU INC | 160.87 Thousand USD | -1094.029% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -5.758% |
| International Stem Cell Corporation | 5.27 Million USD | 63.557% |
| Bioxytran, Inc. | 3.82 Million USD | 49.716% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -3548.999% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -9342.59% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | 94.703% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -18.721% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -161.051% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | 38.254% |
| Neutra Corp. | 243.82 Thousand USD | -687.835% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | 88.996% |
| PureTech Health plc | 144.59 Million USD | 98.672% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | 90.625% |
| IXICO plc | 4.7 Million USD | 59.19% |
| IntelGenx Technologies Corp. | 8.79 Million USD | 78.164% |
| Gelesis Holdings, Inc. | 117.74 Million USD | 98.369% |
| CSL Limited | 3.89 Billion USD | 99.951% |
| Cellectis S.A. | 97.32 Million USD | 98.026% |